Submit a regulatory application for BEAM-302
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 8 Nov 2023
- Due
- 31 Mar 2024
- Delivered
- March 2024
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“The company expects to submit a regulatory application in the first quarter of 2024 for authorization to initiate clinical trials”
What we found
Evidence strength A What the grades mean
Beam Therapeutics announced in March 2024 that its clinical trial authorisation application for BEAM-302 had been cleared by the United Kingdom's regulatory agency, meeting the first-quarter deadline.
-
A Beam Therapeutics Inc. 10-Q filed 2024-05-07
“In March 2024, we announced the clearance of our clinical trial authorisation application, or CTA, for BEAM-302 for the treatment of AATD by the United Kingdom Medicines and Healthcare Products Regulatory Agency.” ✓ confirmed on the page
Market reaction: the shares moved -1.8% against the S&P 500 over the three sessions around the disclosure (6 May 2024 to 9 May 2024). What this measures
Checked 2 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Regulatory filing
- Indicative materiality
- Medium rules
- Action
- Submit
- Deliverable
- BEAM-302 regulatory application
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Beam Therapeutics Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2023-BEAM-003255 · Corrections policy